Quotes 5-day view Delayed Nasdaq
10/20/2020
10/21/2020
10/22/2020
10/23/2020
10/26/2020
Date
27.25(c)
27.04(c)
27.33(c)
27(c)
25.54 Last
903 224
440 420
453 682
425 914
189 221 Volume
+0.04% -0.77% +1.07% -1.21% -5.41% Change
Sales 2020
4 174 M - -
Net income 2020
3,20 M - -
Net Debt 2020
712 M - -
P/E ratio 2020
-1 157x
Yield 2020
-
Sales 2021
4 406 M - -
Net income 2021
11,1 M - -
Net Debt 2021
586 M - -
P/E ratio 2021
352x
Yield 2021
-
Capitalization
3 439 M 3 439 M -
EV / Sales 2020
0,99x
EV / Sales 2021
0,91x
Nbr of Employees
5 300
Free-Float
88,9%
Covetrus, Inc. is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. The Company operates in three segments: North America, Europe and APCA & Emerging Markets. The Company combines practice management software and supply chain distribution businesses with a technology-enabled prescription management platform and related pharmacy...
Notations Surperformance© of Covetrus, Inc.
Trading Rating : Investor Rating :
All news about COVETRUS, INC.
News in other languages on COVETRUS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends COVETRUS, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
8
Average target price
22,25 $
Last Close Price
27,00 $
Spread / Highest target
11,1%
Spread / Average Target
-17,6%
Spread / Lowest Target
-40,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
